Fierce Biotech Names Amylyx Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2020 | Business Wire
Media
Media
Amylyx to Seek AMX0035's Approval for ALS in Europe
Xconomy: Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer's
Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS | Business Wire
Media
Amylyx Pharmaceuticals Announces FDA Advisory Committee Will Reconvene to Review New Drug Application for AMX0035 for the Treatm
Gina Mazzariello on LinkedIn: I am excited and privileged to join Amylyx Pharmaceuticals and support
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IOKLMV5D5RNP7FTEWUHMHQCFGU.jpg "Amylyx's ALS drug gets U.S. FDA panel's backing in rare turnaround | Reuters")
Amylyx's ALS drug gets U.S. FDA panel's backing in rare turnaround | Reuters
Amylyx - FINN Partners
Amylyx Donates CENTAUR Records to PRO-ACT Trials Database for ALS | Data From ALS Trial's Placebo Arm Now Freely Available to Researchers | ALS News Today
European Medicines Agency Grants Orphan Drug Designation to Amylyx Pharmaceuticals' AMX0035 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) | Business Wire
Amylyx Enrolls First ALS Patients in Phase 2 Extension Trial of AMX0035
Amylyx Pharmaceuticals Inc.: Stock Market News and Information
ALS drug wins FDA approval despite questionable data | FOX8 WGHP
Amylyx eyes IPO to support ALS drug filings across the world after FDA U-turn | Fierce Biotech
Amylyx Seeks U.S. Approval of AMX0035 for ALS With FDA Filing
Amylyx Stock: ALS Drug Application Hangs In The Balance (NASDAQ:AMLX) | Seeking Alpha
Amylyx wins approval for first ALS drug - Boston Business Journal
Amylyx Pharmaceuticals sur LinkedIn : Amylyx Pharmaceuticals Announces ALBRIOZA™ is Now Available in Canada for… | 23 commentaires
Amylyx (@AmylyxPharma) / Twitter
Community Conversation with Amylyx - YouTube
Amylyx's ALS drug faces tough FDA scrutiny—again
Amylyx Pharmaceuticals | LinkedIn
